tiprankstipranks
Trending News
More News >
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Income Statement

Compare
660 Followers

Palisade Bio Income Statement

Last quarter (Q4 2025), Palisade Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Palisade Bio's net income was $-8.90M. See Palisade Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 250.00K$ 0.00$ 0.00
Gross Profit
$ -3.00K$ 0.00$ 250.00K$ 0.00$ 0.00
Operating Expenses
$ 18.06M$ 14.86M$ 13.32M$ 15.72M$ 41.85M
Depreciation and Amortization
$ 3.00K$ 3.00K$ 4.00K$ 3.00K$ 2.00K
EBITDA
$ -18.06M$ -14.42M$ -12.28M$ -14.24M$ -24.22M
Operating Income
$ -18.06M$ -14.86M$ -13.07M$ -15.72M$ -41.85M
Other Income/Expenses
$ 1.27M$ 421.00K$ 770.00K$ 1.46M$ 15.24M
Pretax Income
$ -16.78M$ -14.44M$ -12.30M$ -14.26M$ -26.62M
Net Income
$ -16.78M$ -14.44M$ -12.30M$ -14.26M$ -26.62M
Per Share Metrics
Basic EPS
$ -0.30$ -10.19$ -27.01$ -16.53$ -2.14K
Diluted EPS
$ -0.30$ -10.19$ -27.01$ -16.53$ -2.55K
Weighted Average Shares Outstanding
55.67M 1.42M 456.01K 880.10K 12.41K
Weighted Average Shares Outstanding (Diluted)
55.67M 1.42M 456.01K 880.30K 12.46K
Currency in USD

Palisade Bio Earnings and Revenue History